SIRT1 and breast cancer: Benzothiazole derivatives (7ab and 7ba) (Figure 1) that inhibit SIRT1, SIRT2, and SIRT3 in MCF-7 breast cancer cells reduced cell proliferation with IC50 values of 11.4 μM and 9.6 μM.